We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Axonics Modulation Technologies Inc (AXNX) USD0.0001

Sell:$67.18 Buy:$67.22 Change: $0.06 (0.09%)
NASDAQ:1.15%
Market closed |  Prices as at close on 17 April 2024 | Switch to live prices |
Sell:$67.18
Buy:$67.22
Change: $0.06 (0.09%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 April 2024 | Switch to live prices |
Sell:$67.18
Buy:$67.22
Change: $0.06 (0.09%)
Market closed |  Prices as at close on 17 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Axonics, Inc. is a medical technology company, which develops and commercializes products to treat adults with bladder and bowel dysfunction. The Company has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10cc in volume, utilizes constant current stimulation, an easy-to-use, intuitive recharge-free patient remote control and other related accessories. It engineered its recharge-free sacral neuromodulation (SNM) system to deliver constant-current stimulation. Its SNM system includes an easy-to-use wireless patient remote control that does not require recharging or replacement batteries.

Contact details

Address:
26 Technology Drive
IRVINE
92618
United States
Telephone:
+1 (949) 3966322
Website:
https://www.axonics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AXNX
ISIN:
US05465P1012
Market cap:
$3.43 billion
Shares in issue:
51.00 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Raymond Cohen
    Chief Executive Officer, Director
  • Kari Keese
    Chief Financial Officer
  • Rinda Sama
    Chief Operating Officer
  • John Woock
    Executive Vice President, Chief Marketing and Strategy Officer
  • Alfred Ford
    Chief Commercial Officer
  • Karen Noblett
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.